BDBM800261 N-hydroxy-4-(2-((3-hydroxy-4-oxo-2-(2-(trifluoromethyl)phenyl)-1,4-dihydroquinolin-6-yl)amino)-2-oxoethyl)benzamide::US20260085046, Compound Cpd045

SMILES O=C(Cc1ccc(C(=O)NO)cc1)Nc1ccc2[nH]c(-c3ccccc3C(F)(F)F)c(O)c(=O)c2c1

InChI Key InChIKey=UZQJUZQKNFYSBB-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 800261   

TargetHistone deacetylase 1(Human)
Taiwanj Pharmaceuticals Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 800261BDBM800261(N-hydroxy-4-(2-((3-hydroxy-4-oxo-2-(2-(trifluorome...)
Affinity DataIC50: 300nMAssay Description:The pan-HDAC in vitro activity is detected by HDAC-Glo™/II Assay and Screening System (#G6420, Promega, WI, USA). This system is single-reagent-addit...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
8/5/2026
Entry Details
US Patent